Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


PEOPLE: changes in Novozymes' executive management:

Novozymes (Bagsvaerd, Denmark) is appointing two new executive vice-presidents, Dr Thomas Videbaek and Thomas Nagy. Dr Videbaek, who is currently vice-president of global enzyme sales, will become executive vice-president of biobusiness outside the enzyme area. Mr Nagy, site president of Novozymes North America, will be appointed executive vice-president of stakeholder relations. Dr Videbaek and Mr Nagy will take up their new posts on October 1st and, on the same date, Arne Schmidt, who is currently executive vice-president of development, production and quality, will retire after 37 years with Novo Nordisk and Novozymes.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts